Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Arbor Realty raises quarterly dividend to 35c per share » 08:13
07/30/21
07/30
08:13
07/30/21
08:13
ABR

Arbor Realty

$18.12 /

+0.12 (+0.67%)

The Company announced…

The Company announced that its Board of Directors has declared a quarterly cash dividend of $0.35 per share of common stock for the quarter ended June 30, 2021, the Company's fifth consecutive quarterly increase, representing a 12.9% increase from a year ago. The dividend is payable on August 31, 2021 to common stockholders of record on August 16, 2021. The ex-dividend date is August 13, 2021.

ShowHide Related Items >><<
ABR Arbor Realty
$18.12 /

+0.12 (+0.67%)

ABR Arbor Realty
$18.12 /

+0.12 (+0.67%)

04/26/21 JPMorgan
Arbor Realty price target raised to $18 from $16.50 at JPMorgan
11/06/20 Wolfe Research
Arbor Realty initiated with an Outperform at Wolfe Research
ABR Arbor Realty
$18.12 /

+0.12 (+0.67%)

  • 15
    Jun
  • 26
    Mar
  • 11
    Nov
ABR Arbor Realty
$18.12 /

+0.12 (+0.67%)

Earnings
Arbor Realty reports Q2 distributable EPS 45c, consensus 40c » 08:12
07/30/21
07/30
08:12
07/30/21
08:12
ABR

Arbor Realty

$18.12 /

+0.12 (+0.67%)

GAAP book value of…

GAAP book value of $10.97, or $11.35 per common share adjusted for $61.0 million of CECL general reserves.

ShowHide Related Items >><<
ABR Arbor Realty
$18.12 /

+0.12 (+0.67%)

ABR Arbor Realty
$18.12 /

+0.12 (+0.67%)

04/26/21 JPMorgan
Arbor Realty price target raised to $18 from $16.50 at JPMorgan
11/06/20 Wolfe Research
Arbor Realty initiated with an Outperform at Wolfe Research
ABR Arbor Realty
$18.12 /

+0.12 (+0.67%)

  • 15
    Jun
  • 26
    Mar
  • 11
    Nov
ABR Arbor Realty
$18.12 /

+0.12 (+0.67%)

Wednesday
Hot Stocks
Fusion Pharmaceuticals says FDA clears IND for FPI-1966 » 16:59
07/28/21
07/28
16:59
07/28/21
16:59
FUSN

Fusion Pharmaceuticals

$8.17 /

+0.14 (+1.74%)

Fusion Pharmaceuticals…

Fusion Pharmaceuticals announced that the U.S. FDA has cleared the company's Investigational New Drug applications for [225Ac]-FPI-1966 (FPI-1966) and imaging agent [111In]-FPI-1967 (FPI-1967). FPI-1966 is a targeted alpha therapy designed to use vofatamab, a human monoclonal antibody, to target and deliver actinium-225 to tumor sites expressing fibroblast growth factor 3, a protein that is overexpressed in multiple tumor types, particularly head and neck and bladder cancers. FPI-1966 utilizes Fusion's Fast-Clear linker to connect vofatamab to actinium-225.

ShowHide Related Items >><<
FUSN Fusion Pharmaceuticals
$8.17 /

+0.14 (+1.74%)

FUSN Fusion Pharmaceuticals
$8.17 /

+0.14 (+1.74%)

FUSN Fusion Pharmaceuticals
$8.17 /

+0.14 (+1.74%)

FUSN Fusion Pharmaceuticals
$8.17 /

+0.14 (+1.74%)

Options
new option listings on July 28th » 08:30
07/28/21
07/28
08:30
07/28/21
08:30
ACHV

Achieve Life Sciences

$7.29 /

-0.35 (-4.58%)

, ADES

Advanced Emissions

$7.42 /

+0.27 (+3.78%)

, ALGS

Aligos Therapeutics

$15.07 /

-0.43 (-2.77%)

, ATCX

Atlas Technical Consultants

$8.98 /

-0.45 (-4.77%)

, BBCP

Concrete Pumping

$8.61 /

+0.13 (+1.53%)

, BTTR

Better Choice Company

$3.47 /

-0.45 (-11.48%)

, CDAK

Codiak

$16.35 /

-0.11 (-0.67%)

, CGA

China Green

$9.65 /

-0.51 (-5.02%)

, CHMI

Cherry Hill Mortgage

$9.42 /

+0.04 (+0.43%)

, CRCT

Cricut

$34.01 /

-3.02 (-8.16%)

, CRTD

Creatd

$3.17 /

-0.01 (-0.31%)

, DRTT

Dirtt Environmental

$4.18 /

+0.03 (+0.72%)

, EARN

Ellington Residential

$11.12 /

-0.06 (-0.54%)

, EPS

WisdomTree Earnings 500

$47.00 /

-0.3 (-0.63%)

, ESXB

Community Bankers Trust

$10.65 /

-0.06 (-0.56%)

, EZM

E-Z-EM

$51.80 /

-0.15 (-0.29%)

, HMLP

Hoegh LNG Partners

$17.76 /

-0.11 (-0.62%)

, ICL

ICL

$7.06 /

-0.07 (-0.98%)

, IMXI

International Money Express

$15.76 /

-0.09 (-0.57%)

, INTT

inTEST

$13.53 /

-0.65 (-4.58%)

, LIQT

LiqTech

$6.40 /

+0.19 (+3.06%)

, MDWD

MediWound

$4.08 /

+0.26 (+6.81%)

, PSJ

PwerShares Dynamic Software

$157.72 /

-2.98 (-1.85%)

, RTPY

Reinvent Technology Partners Y

$9.91 /

-0.02 (-0.20%)

, SGTX

Sigilon Therapeutics

$5.31 /

+0.32 (+6.41%)

, SIC

Select Interior Concepts

$10.47 /

+0.18 (+1.75%)

, USDP

USD Partners

$6.66 /

-0.16 (-2.35%)

, VIRI

Virios Therapeutics

$5.64 /

-0.06 (-1.05%)

, VYGG

Vy Global Growth

$9.79 /

-0.04 (-0.41%)

New option listings for…

New option listings for July 28th include Achieve Life Sciences Inc (ACHV), Advanced Emissions (ADES), Market Vectors Africa (AFK), Aligos Therapeutics Inc (ALGS), Atlas Technical Consultants Inc (Class A Stock) (ATCX), Concrete Pumping Holdings Inc (BBCP), Better Choice Company Inc (BTTR), CBX (CBX), Codiak BioSciences Inc (CDAK), China Green (CGA), Cherry Hill Mortgage (CHMI), Cricut Inc (CRCT), Creatd Inc (CRTD), WisdomTree High Dividend Fund (DHS), Dirtt Environmental Solutions Ltd (DRTT), Ellington Residential (EARN), WisdomTree SmallCap Earnings Fund (EES), WisdomTree Earnings 500 Fund (EPS), Community Bankers Trust (ESXB), WisdomTree MidCap Earnings Fund (EZM), Hoegh LNG (HMLP), IBO (IBO), Israel Chemicals (ICL), iShares Evolved US Technology ETF (IETC), iShares Edge MSCI Intl Momentum Factor ETF (IMTM), International Money Express Inc (IMXI), inTest (INTT), WisdomTree International Quality Dividend Growth Fund (IQDG), iShares Russell Top 200 (IWL), iShares Russell Top 200 Value (IWX), iShares Dow Jones US (IYY), SPDR Russell 1000 Low Volatility ETF (LGLV), LiqTech (LIQT), MediWound (MDWD), Power Shares Food And Beverage (PBJ), PowerShares S&P 500 Buy Write Portfolio (PBP), PowerShares Dynamic Media Portfolio (PBS), PowerShares FTSE RAFI Developed Markets Ex US Sm Mid Portfolio (PDN), PowerShares Dynamic Building and Construction Portfolio (PKB), PowerShares S&P SmallCap Consumer Discretionary Portfolio (PSCD), Power Shares Dynamic Software Portfolio (PSJ), Powershares Dynamic Large Cap Growth Portfolio (PWB), Powershares Dynamic Large Cap Value Portfolio (PWV), PowerShares FTSE RAFI Developed Markets ex US Portfolio (PXF), PowerShares DWA Basic Materials Momentum Portfolio (PYZ), Reinvent Technology Partners Y (Class A Stock) (RTPY), Sigilon Therapeutics Inc (SGTX), Select Interior Concepts Inc (Class A Stock) (SIC), Presidio Property Trust Inc (Class A Stock) (SQFT), USD Partners (USDP), Virios Therapeutics Inc (VIRI), Vy Global Growth (Class A Stock) (VYGG), WisdomTree Cybersecurity Fund (WCBR), Innovative Technology ETF (XITK), and SPDR NYSE Technology (XNTK).

ShowHide Related Items >><<
VIRI Virios Therapeutics
$5.64 /

-0.06 (-1.05%)

USDP USD Partners
$6.66 /

-0.16 (-2.35%)

SIC Select Interior Concepts
$10.47 /

+0.18 (+1.75%)

SGTX Sigilon Therapeutics
$5.31 /

+0.32 (+6.41%)

RTPY Reinvent Technology Partners Y
$9.91 /

-0.02 (-0.20%)

MDWD MediWound
$4.08 /

+0.26 (+6.81%)

INTT inTEST
$13.53 /

-0.65 (-4.58%)

IMXI International Money Express
$15.76 /

-0.09 (-0.57%)

ICL ICL
$7.06 /

-0.07 (-0.98%)

HMLP Hoegh LNG Partners
$17.76 /

-0.11 (-0.62%)

ESXB Community Bankers Trust
$10.65 /

-0.06 (-0.56%)

EARN Ellington Residential
$11.12 /

-0.06 (-0.54%)

DRTT Dirtt Environmental
$4.18 /

+0.03 (+0.72%)

CRTD Creatd
$3.17 /

-0.01 (-0.31%)

CRCT Cricut
$34.01 /

-3.02 (-8.16%)

CGA China Green
$9.65 /

-0.51 (-5.02%)

CDAK Codiak
$16.35 /

-0.11 (-0.67%)

BTTR Better Choice Company
$3.47 /

-0.45 (-11.48%)

BBCP Concrete Pumping
$8.61 /

+0.13 (+1.53%)

ATCX Atlas Technical Consultants
$8.98 /

-0.45 (-4.77%)

ALGS Aligos Therapeutics
$15.07 /

-0.43 (-2.77%)

ADES Advanced Emissions
$7.42 /

+0.27 (+3.78%)

ACHV Achieve Life Sciences
$7.29 /

-0.35 (-4.58%)

ACHV Achieve Life Sciences
$7.29 /

-0.35 (-4.58%)

07/22/21 Lake Street
NIH grant opens new opportunity for Achieve's cytisinicline, says Lake Street
07/20/21 Lake Street
Achieve Life weakness on Chantix news would be opportunity, says Lake Street
07/06/21 Lake Street
Achieve Life Sciences weakness a buying opportunity, says Lake Street
06/25/21 Lake Street
Achieve Life Sciences not hurt by Chantix recall, says Lake Street
ADES Advanced Emissions
$7.42 /

+0.27 (+3.78%)

ALGS Aligos Therapeutics
$15.07 /

-0.43 (-2.77%)

07/08/21 Piper Sandler
Aligos should be bought into 'catalyst rich' second half, says Piper Sandler
06/21/21 Piper Sandler
Aligos reported 'robust data' in hepatitis B virus, says Piper Sandler
06/10/21 Piper Sandler
Aligos Therapeutics has data-rich month with robust lineup, says Piper Sandler
05/17/21 Piper Sandler
Aligos Therapeutics assumed with an Overweight at Piper Sandler
ATCX Atlas Technical Consultants
$8.98 /

-0.45 (-4.77%)

01/08/21
Fly Intel: Top five analyst initiations
01/08/21 Stifel
Atlas Technical Consultants initiated with a Buy at Stifel
08/11/20 DA Davidson
Atlas Technical Consultants upgraded to Buy from Neutral at DA Davidson
08/11/20 DA Davidson
Atlas Technical Consultants upgraded to Buy from Neutral at DA Davidson
BBCP Concrete Pumping
$8.61 /

+0.13 (+1.53%)

06/25/21 UBS
Concrete Pumping upgraded to Buy from Neutral at UBS
06/16/21 DA Davidson
Concrete Pumping price target raised to $11 from $9 at DA Davidson
06/15/21 Baird
Concrete Pumping price target raised to $11 from $10 at Baird
04/22/21 Baird
Concrete Pumping price target raised to $9 from $8 at Baird
BTTR Better Choice Company
$3.47 /

-0.45 (-11.48%)

07/26/21 Roth Capital
Better Choice Company initiated with a Buy at Roth Capital
07/15/21 DA Davidson
Better Choice Company initiated with a Buy at DA Davidson
07/15/21 DA Davidson
Better Choice Company initiated with a Buy at DA Davidson
CDAK Codiak
$16.35 /

-0.11 (-0.67%)

12/31/20 Wedbush
Codiak price target raised to $31 from $19 at Wedbush
11/09/20
Fly Intel: Top five analyst initiations
11/09/20 Wedbush
Codiak initiated with an Outperform at Wedbush
11/08/20 Goldman Sachs
Codiak initiated with a Buy at Goldman Sachs
CGA China Green
$9.65 /

-0.51 (-5.02%)

CHMI Cherry Hill Mortgage
$9.42 /

+0.04 (+0.43%)

04/20/21 B. Riley
Cherry Hill Mortgage transferred with Buy, $11.50 target at B. Riley
11/10/20 Piper Sandler
Cherry Hill Mortgage downgraded to Neutral from Overweight at Piper Sandler
CRCT Cricut
$34.01 /

-3.02 (-8.16%)

06/10/21 Morgan Stanley
Cricut downgraded to Equal Weight from Overweight at Morgan Stanley
05/14/21 Barclays
Cricut price target raised to $28 from $26 at Barclays
04/19/21
Fly Intel: Top five analyst initiations
04/19/21 Citi
Cricut initiated with a Buy at Citi
CRTD Creatd
$3.17 /

-0.01 (-0.31%)

DRTT Dirtt Environmental
$4.18 /

+0.03 (+0.72%)

05/06/21 National Bank
Dirtt Environmental downgraded to Sector Perform from Outperform at National Bank
05/06/21 National Bank
Dirtt downgraded to Sector Perform from Outperform at National Bank
12/31/20
Fly Intel: Top five analyst calls
12/31/20 Industrial Alliance
DIRTT Environmental downgraded to Sell from Hold at Industrial Alliance
EARN Ellington Residential
$11.12 /

-0.06 (-0.54%)

11/23/20 BTIG
Ellington Residential initiated with a Buy at BTIG
EPS WisdomTree Earnings 500
$47.00 /

-0.3 (-0.63%)

ESXB Community Bankers Trust
$10.65 /

-0.06 (-0.56%)

02/03/21 Stephens
Stephens cuts Community Bankers Trust to Equal Weight as stock nears $8 target
02/03/21 Stephens
Community Bankers Trust downgraded to Equal Weight from Overweight at Stephens
EZM E-Z-EM
$51.80 /

-0.15 (-0.29%)

HMLP Hoegh LNG Partners
$17.76 /

-0.11 (-0.62%)

07/28/21 B. Riley
Hoegh LNG Partners downgraded to Neutral from Buy at B. Riley
07/28/21 B. Riley
Hoegh LNG Partners downgraded to Neutral from Buy at B. Riley
07/28/21 Barclays
Hoegh LNG Partners downgraded to Underweight from Overweight at Barclays
03/10/21 Danske Bank
Hoegh LNG Partners upgraded to Hold from Sell at Danske Bank
ICL ICL
$7.06 /

-0.07 (-0.98%)

11/23/20 Stephens
ICL downgraded to Equal Weight with $5.50 price target at Stephens
11/23/20 Stephens
ICL downgraded to Equal Weight from Overweight at Stephens
IMXI International Money Express
$15.76 /

-0.09 (-0.57%)

05/05/21 BTIG
International Money earnings selloff a buying opportunity, says BTIG
08/17/20 BTIG
International Money Express price target raised to $22 from $17 at BTIG
08/05/20 Cantor Fitzgerald
International Money price target raised to $21 from $11 at Cantor Fitzgerald
08/05/20 JMP Securities
International Money Express upgraded to Outperform at JMP Securities
INTT inTEST
$13.53 /

-0.65 (-4.58%)

05/10/21 Lake Street
inTEST price target raised to $16 from $11 at Lake Street
03/08/21 Lake Street
inTEST price target raised to $11 from $6 at Lake Street
LIQT LiqTech
$6.40 /

+0.19 (+3.06%)

10/15/20 Stephens
LiqTech resumed with an Equal Weight at Stephens
10/02/20 B. Riley
LiqTech price target raised to $11 from $8 at B. Riley Securities
MDWD MediWound
$4.08 /

+0.26 (+6.81%)

06/29/21 Oppenheimer
MediWound NexoBrid CRL as expected, says Oppenheimer
03/02/21 Aegis
MediWound initiated with a Buy at Aegis
02/26/21 H.C. Wainwright
MediWound price target raised to $7 from $5.50 at H.C. Wainwright
10/19/20 BTIG
Vericel price target raised to $30 from $23 at BTIG
PSJ PwerShares Dynamic Software
$157.72 /

-2.98 (-1.85%)

RTPY Reinvent Technology Partners Y
$9.91 /

-0.02 (-0.20%)

SGTX Sigilon Therapeutics
$5.31 /

+0.32 (+6.41%)

07/19/21 Canaccord
Sigilon Therapeutics price target lowered to $43 from $62 at Canaccord
12/29/20 Barclays
Sigilon Therapeutics initiated with an Overweight at Barclays
12/29/20 Morgan Stanley
Sigilon Therapeutics initiated with an Equal Weight at Morgan Stanley
12/29/20 Jefferies
Sigilon Therapeutics initiated with a Buy at Jefferies
SIC Select Interior Concepts
$10.47 /

+0.18 (+1.75%)

03/16/21 B. Riley
Select Interior Concepts price target raised to $14 from $13 at B. Riley
02/02/21 B. Riley
Select Interior looks attractive relative to Blackstone deal, says B. Riley
01/22/21 B. Riley
Select Interior Concepts price target raised to $13 from $12 at B. Riley
09/11/20 Truist
Select Interior Concepts initiated with a Buy at Truist
USDP USD Partners
$6.66 /

-0.16 (-2.35%)

VIRI Virios Therapeutics
$5.64 /

-0.06 (-1.05%)

VYGG Vy Global Growth
$9.79 /

-0.04 (-0.41%)

SIC Select Interior Concepts
$10.47 /

+0.18 (+1.75%)

SGTX Sigilon Therapeutics
$5.31 /

+0.32 (+6.41%)

MDWD MediWound
$4.08 /

+0.26 (+6.81%)

LIQT LiqTech
$6.40 /

+0.19 (+3.06%)

INTT inTEST
$13.53 /

-0.65 (-4.58%)

IMXI International Money Express
$15.76 /

-0.09 (-0.57%)

ICL ICL
$7.06 /

-0.07 (-0.98%)

HMLP Hoegh LNG Partners
$17.76 /

-0.11 (-0.62%)

ESXB Community Bankers Trust
$10.65 /

-0.06 (-0.56%)

EARN Ellington Residential
$11.12 /

-0.06 (-0.54%)

CRTD Creatd
$3.17 /

-0.01 (-0.31%)

CHMI Cherry Hill Mortgage
$9.42 /

+0.04 (+0.43%)

CDAK Codiak
$16.35 /

-0.11 (-0.67%)

BTTR Better Choice Company
$3.47 /

-0.45 (-11.48%)

BBCP Concrete Pumping
$8.61 /

+0.13 (+1.53%)

ALGS Aligos Therapeutics
$15.07 /

-0.43 (-2.77%)

  • 29
    Jun
  • 01
    Jul
  • 17
    Jun
  • 15
    Jun
  • 25
    May
  • 25
    Mar
  • 12
    Feb
  • 17
    Dec
  • 03
    Dec
  • 04
    Dec
  • 16
    Oct
  • 14
    Oct
  • 01
    Oct
  • 14
    Aug
RTPY Reinvent Technology Partners Y
$9.91 /

-0.02 (-0.20%)

SGTX Sigilon Therapeutics
$5.31 /

+0.32 (+6.41%)

RTPY Reinvent Technology Partners Y
$9.91 /

-0.02 (-0.20%)

MDWD MediWound
$4.08 /

+0.26 (+6.81%)

INTT inTEST
$13.53 /

-0.65 (-4.58%)

ESXB Community Bankers Trust
$10.65 /

-0.06 (-0.56%)

DRTT Dirtt Environmental
$4.18 /

+0.03 (+0.72%)

CRTD Creatd
$3.17 /

-0.01 (-0.31%)

CRCT Cricut
$34.01 /

-3.02 (-8.16%)

CDAK Codiak
$16.35 /

-0.11 (-0.67%)

BBCP Concrete Pumping
$8.61 /

+0.13 (+1.53%)

ACHV Achieve Life Sciences
$7.29 /

-0.35 (-4.58%)

Hot Stocks
PDS Biotechnology to present Phase 2 human clinical data » 08:12
07/28/21
07/28
08:12
07/28/21
08:12
PDSB

PDS Biotechnology

$9.32 /

-0.04 (-0.43%)

PDS Biotechnology…

PDS Biotechnology announced that its management team will present at several investor conferences listed below during the third quarter of 2021. At the recent American Society of Clinical Oncology 2021 Annual Meeting, interim data was presented in an oral session on PDS Biotech's lead asset, PDS0101, in combination with two investigational immune-modulating agents being studied in two groups of advanced cancer patients. In the first group of patients who had failed treatment with chemotherapy and radiation, tumor reduction was seen in 83% of patients. In the second group, patients who in addition had failed treatment with checkpoint inhibitors, tumor reduction was seen in 58% patients.

ShowHide Related Items >><<
PDSB PDS Biotechnology
$9.32 /

-0.04 (-0.43%)

PDSB PDS Biotechnology
$9.32 /

-0.04 (-0.43%)

06/28/21 Cantor Fitzgerald
PDS Biotechnology initiated with an Overweight at Cantor Fitzgerald
06/09/21 Oppenheimer
PDS Biotechnology price target raised to $25 from $12 at Oppenheimer
06/09/21 Alliance Global Partners
PDS Biotechnology price target raised to $18 from $6.50 at Alliance Global Partners
06/08/21 Chardan
PDS Biotechnology price target raised to $15 from $11 at Chardan
PDSB PDS Biotechnology
$9.32 /

-0.04 (-0.43%)

  • 15
    Jun
  • 11
    Aug
PDSB PDS Biotechnology
$9.32 /

-0.04 (-0.43%)

PDSB PDS Biotechnology
$9.32 /

-0.04 (-0.43%)

Over a week ago
Conference/Events
Concrete Pumping management to meet virtually with » 12:08
07/08/21
07/08
12:08
07/08/21
12:08
BBCP

Concrete Pumping

$8.02 /

-0.16 (-1.96%)

Virtual Meeting to be…

Virtual Meeting to be held

ShowHide Related Items >><<
BBCP Concrete Pumping
$8.02 /

-0.16 (-1.96%)

BBCP Concrete Pumping
$8.02 /

-0.16 (-1.96%)

06/25/21 UBS
Concrete Pumping upgraded to Buy from Neutral at UBS
06/16/21 DA Davidson
Concrete Pumping price target raised to $11 from $9 at DA Davidson
06/15/21 Baird
Concrete Pumping price target raised to $11 from $10 at Baird
04/22/21 Baird
Concrete Pumping price target raised to $9 from $8 at Baird
BBCP Concrete Pumping
$8.02 /

-0.16 (-1.96%)

BBCP Concrete Pumping
$8.02 /

-0.16 (-1.96%)

Syndicate
Fusion Pharmaceuticals files $400M mixed securities shelf  16:27
07/02/21
07/02
16:27
07/02/21
16:27
FUSN

Fusion Pharmaceuticals

$8.16 /

+0.08 (+0.99%)

 
ShowHide Related Items >><<
FUSN Fusion Pharmaceuticals
$8.16 /

+0.08 (+0.99%)

FUSN Fusion Pharmaceuticals
$8.16 /

+0.08 (+0.99%)

07/21/20
Fly Intel: Top five analyst initiations
07/21/20 Morgan Stanley
Fusion Pharmaceuticals initiated with an Overweight at Morgan Stanley
07/21/20 Wedbush
Wedbush bullish on Fusion Pharmaceuticals, initiates with an Outperform
07/21/20 Jefferies
Fusion Pharmaceuticals initiated with a Buy at Jefferies
FUSN Fusion Pharmaceuticals
$8.16 /

+0.08 (+0.99%)

FUSN Fusion Pharmaceuticals
$8.16 /

+0.08 (+0.99%)

FUSN Fusion Pharmaceuticals
$8.16 /

+0.08 (+0.99%)

Hot Stocks
PDS Biotechnology joins Russell Microcap Index » 08:36
07/01/21
07/01
08:36
07/01/21
08:36
PDSB

PDS Biotechnology

$12.54 /

+0.83 (+7.09%)

PDS Biotechnology…

PDS Biotechnology Corporation was added to the Russell Microcap Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective on June 28, according to the FTSE Russell website.

ShowHide Related Items >><<
PDSB PDS Biotechnology
$12.54 /

+0.83 (+7.09%)

PDSB PDS Biotechnology
$12.54 /

+0.83 (+7.09%)

06/28/21 Cantor Fitzgerald
PDS Biotechnology initiated with an Overweight at Cantor Fitzgerald
06/09/21 Oppenheimer
PDS Biotechnology price target raised to $25 from $12 at Oppenheimer
06/09/21 Alliance Global Partners
PDS Biotechnology price target raised to $18 from $6.50 at Alliance Global Partners
06/08/21 Chardan
PDS Biotechnology price target raised to $15 from $11 at Chardan
PDSB PDS Biotechnology
$12.54 /

+0.83 (+7.09%)

  • 15
    Jun
  • 11
    Aug
PDSB PDS Biotechnology
$12.54 /

+0.83 (+7.09%)

PDSB PDS Biotechnology
$12.54 /

+0.83 (+7.09%)

Over a month ago
Initiation
PDS Biotechnology initiated with an Overweight at Cantor Fitzgerald » 07:17
06/28/21
06/28
07:17
06/28/21
07:17
PDSB

PDS Biotechnology

$10.98 /

+0.31 (+2.91%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Louise Chen initiated coverage of PDS Biotechnology with an Overweight rating and $25 price target. The analyst believes the peak sales potential of the company's pipeline is underappreciated. Upwards earnings revision, driven by pipeline advancements, should move the stock higher, Chen tells investors in a research note. She believes PDS has shown promising early data in both oncology and infectious diseases.

ShowHide Related Items >><<
PDSB PDS Biotechnology
$10.98 /

+0.31 (+2.91%)

PDSB PDS Biotechnology
$10.98 /

+0.31 (+2.91%)

06/09/21 Oppenheimer
PDS Biotechnology price target raised to $25 from $12 at Oppenheimer
06/09/21 Alliance Global Partners
PDS Biotechnology price target raised to $18 from $6.50 at Alliance Global Partners
06/08/21 Chardan
PDS Biotechnology price target raised to $15 from $11 at Chardan
06/02/21 H.C. Wainwright
PDS Biotechnology price target raised to $20 from $8 at H.C. Wainwright
PDSB PDS Biotechnology
$10.98 /

+0.31 (+2.91%)

  • 15
    Jun
  • 11
    Aug
PDSB PDS Biotechnology
$10.98 /

+0.31 (+2.91%)

PDSB PDS Biotechnology
$10.98 /

+0.31 (+2.91%)

Upgrade
Concrete Pumping upgraded to Buy from Neutral at UBS » 06:06
06/25/21
06/25
06:06
06/25/21
06:06
BBCP

Concrete Pumping

$8.50 /

+0.18 (+2.16%)

UBS analyst Steven Fisher…

UBS analyst Steven Fisher upgraded Concrete Pumping to Buy from Neutral with a price target of $11, up from $6. The analyst believes that a faster than expected recovery in non-residential construction will support his "above-consensus" revenue growth and EBITDA , adding that he now sees "only a deceleration" in sales next year vs. his prior forecast of a 1%-2% decline. Concrete Pumping's leading position in the concrete pumping market is its main competitive advantage, Fisher tells investors in a research note.

ShowHide Related Items >><<
BBCP Concrete Pumping
$8.50 /

+0.18 (+2.16%)

BBCP Concrete Pumping
$8.50 /

+0.18 (+2.16%)

06/16/21 DA Davidson
Concrete Pumping price target raised to $11 from $9 at DA Davidson
06/15/21 Baird
Concrete Pumping price target raised to $11 from $10 at Baird
04/22/21 Baird
Concrete Pumping price target raised to $9 from $8 at Baird
01/13/21 B. Riley
Concrete Pumping price target lowered to $6 from $6.75 at B. Riley Securities
BBCP Concrete Pumping
$8.50 /

+0.18 (+2.16%)

BBCP Concrete Pumping
$8.50 /

+0.18 (+2.16%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.